Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Margetuximab in HER2-positive metastatic breast cancer.
Journal: Future oncology (London, England)
Published: May 12, 2023
Margetuximab (Margenza) for HER2-positive breast cancer.
Journal: The Medical letter on drugs and therapeutics
Published: November 18, 2022
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 09, 2021
Current and Future Management of HER2-Positive Metastatic Breast Cancer.
Journal: JCO oncology practice
Published: June 02, 2021
Margetuximab-cmkb.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: April 06, 2021
Showing 1-7 of 7
Last Updated: 10/31/2025